跳至主要内容
临床试验/NCT02537496
NCT02537496已完成不适用

Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Enhancement of Dorsolateral Prefrontal Cortex Neuroplasticity: A TMS-EEG Study

Centre for Addiction and Mental Health2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2016年1月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
2
主要终点
Change in N-back Task Performance

研究概览

简要总结

In this study the investigators aim at assessing and then enhancing neuroplasticity in the dorsolateral prefrontal cortex (DLPFC) and working memory - a key function of DLPFC - in patients with mild Alzheimer's disease (AD). The investigators will use Paired Associative Stimulation (PAS) paradigm to measure neuroplasticity and then a 4-week course of high-frequency repetitive Transcranial Magnetic Stimulation (rTMS) to the DLPFC to enhance cognitive function. Clinical and cognitive assessments will be done at baseline, one week, one month and 6 months after the rTMS course. Healthy controls will also be enrolled to carry out baseline cognitive assessments and a baseline measurement of neuroplasticity.

详细描述

Specific aim 1: To assess working memory in participants with Alzheimer's disease (AD) and its change in response to a 4-week course of bilateral rTMS of DLPFC.

Hypothesis 1a: Compared to healthy individuals, participants with AD will be impaired on the N-back task.

Hypothesis 1b: Compared to sham rTMS, active rTMS will result in improvement on the N-back task in participants with AD at 1 week and 4 weeks after the treatment.

Specific aim 2: To assess DLPFC theta-gamma coupling during working memory performance in AD and its change in response to a 4-week course of bilateral rTMS of DLPFC.

Hypothesis 2a: Compared to healthy individuals, participants with AD will be impaired on DLPFC theta-gamma coupling during the N-back task.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Active placebo coil will be used as a Sham condition. This coil effectively mimics the real stimulation producing somatic sensation and sound (contraction of scalp muscles) with minimal direct brain effects. Same stimulation parameters and site as active condition will be used.

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Alzheimer's disease rTMS

Experimental

The intervention procedure done in this group is repetitive Transcranial Magnetic Stimulation.

干预措施: Repetitive Transcranial Magnetic Stimulation (Procedure)

Alzheimer's disease rTMS Sham

Sham Comparator

The intervention procedure done in this group is Repetitive Transcranial Magnetic Stimulation - Sham

干预措施: Repetitive Transcranial Magnetic Stimulation - Sham (Procedure)

Healthy Control

No Intervention

Healthy control group will only participate in baseline assessments which include baseline neuropsychological testing and baseline measurement of neuroplasticity. This will be used to standardize neuropsychological test scores and to compare the baseline neuroplasticity between healthy participants and Alzheimer's disease (AD) participants. Healthy control group will not get rTMS intervention.

结局指标

主要结局

Change in N-back Task Performance

时间窗: pre-intervention (baseline) and then 7 days, 4 weeks and 6 months after intervention

The N-Back is a working memory task where the subject is presented with a sequence of stimuli (letters). The task consists of indicating when the current stimulus matches the one from N steps earlier in the sequence. By measuring the accuracy on the N-back task, the investigators will assess the working memory at baseline and compare the change at 7days, 4 weeks and 6 months post-intervention. The investigators' pilot data suggests that this test is most discriminatory between AD participants and healthy controls. The N-back task will be administered while recording EEG online to assess theta-gamma coupling.

次要结局

  • Changes in Cognitive Function Measures Scores(Change from baseline at 7 days, 4 weeks and 6 months after intervention.)
  • Validating a new scale for insight in Alzheimer's disease.(Change from baseline at 7 days and 6 months after intervention.)
  • Changes in Theta Phase-Gamma Amplitude Coupling(Change from baseline at 7 days, 4 weeks and 6 months after intervention.)
  • Changes in DLPFC Neuroplasticity(Change from baseline at 7 days, 4 weeks and 6 months after intervention.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sanjeev Kumar

Sanjeev Kumar, MD, FRCPC

Centre for Addiction and Mental Health

研究点 (2)

Loading locations...

相似试验

Enhancing Working Memory in Patients With Early... | 临床试验